Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 31

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 31
---
 of shares of common stock in this offering the Private Placement Warrants to purchase        
 up to 2,043,098 shares of our common stock at an initial exercise price of $0.771 per share. We will receive proceeds from such warrants 
 solely to the extent they are exercised for cash. The Private Placement Warrants and the shares of our common stock issuable upon        
 the exercise of the warrants are not being offered pursuant to this prospectus supplement and the accompanying prospectus. The Private   
 Placement Warrants will become exercisable immediately upon issuance and will expire twenty-four (24) months from the issuance date.     
 See “Private Placement Transaction.”                                                                                                     |
| Placement agent                                          |     | We have engaged H.C. Wainwright                                                                                                          
 as our exclusive placement agent in connection with this offering. H.C. Wainwright is not required to buy or sell any specific           
 number or dollar amount of the securities offered hereby, but it will use its reasonable best efforts to solicit offers to purchase      
 the securities offered by this prospectus. See “Plan of Distribution” on page S-24 of this prospectus supplement.                        |

| (1) | The number                                                                                                                             
 of shares of common stock to be outstanding after this offering is based on 4,395,505 shares of Common Stock outstanding as of January 
 28, 2025 and excludes:                                                                                                                 |

| ● | 285,373                                                           
 shares of common stock reserved for issuance under the 2022 Plan; |

<div align='center'>S-18</div>

| ● | 945,068                                                                                                                         
 shares of common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $24.50 per share; |

| ● | 444,000                                                                                          
 shares of common stock issuable upon the exercise of outstanding Pre-Funded Warrants to purchase 
 common stock at an exercise price of $0.001 per share;                                           |

| ● | 2,898,551                                                                                     
 shares of common stock issuable upon exercise of outstanding Series A warrants at an exercise 
 price of $1.38 per share;                                                                     |

| ● | 2,898,551                                                                                     
 shares of common stock issuable upon exercise of outstanding Series B warrants at an exercise 
 price of $1.38 per share;                                                                     |

| ● | 7,076                                                                                      
 shares of common stock issuable upon exercise of the representative warrants issued to the 
 representative in our initial public offering at an exercise price of $